Paul Mampilly Says Pharmacy Stocks Aren’t Dead Yet Despite Amazon’s New Venture

Amazon, one of Warren Buffet’s largest stock investments is now partnering with the legendary investor’s firm, Berkshire Hathaway to build a new pharmacy company. This company, which is said to be a planned integration with Amazon’s marketplace is also predicted to be a big healthcare disrupter. The middleman will be cut out in this new company which could affect how current pharmacy chains like CVS and Walgreens also operate. But even though some Wall Street insiders are uneasy about the move by Amazon, investor Paul Mampilly says healthcare stock owners may not be in as much trouble as they think. Read more about Paul Mampilly at Talk Markets.

Mampilly said that Amazon has moved into business niches before with plans to take over them but hasn’t completely succeeded. For example, they appeared to be getting a leg up on Netflix when they announced they were rolling out a big new streaming service through Instant Video and Prime. But Netflix surged back and gained an edge on them again in recent years. They also seemed to drive Kroger’s stock down when they announced their new grocery store alternative plan with Whole Foods. But this new low price disruptive shopping idea hasn’t quite caught on the way they thought, and Kroger’s stock is now up as high as it’s ever been. No doubt there will be some changes to the way prescription drugs are sold with this new plan of Amazon’s, but well-known chains will likely not be going anywhere.

Paul Mampilly worked in big banks for over 10 years, but when it comes to buying stocks he really is his own man. He has the Wall Street credentials with a bachelor’s degree from Montclair State University and a master’s from Fordham, and he was a portfolio manager for Deutsche Bank, Banker’s Trust and ING. He also was a managing director for 7 years at Kinetics International Fund, a big Wall Street hedge fund, and a former winner of the Templeton Foundation investment competition. But he’s been much happier since retiring from the corporate life and now writing his own newsletters.


Paul Mampilly writes three newsletters, “Profits Unlimited,” “Extreme Fortunes” and “True Momentum” for Banyan Hill. He doesn’t actually manage subscribers’ portfolios but he does show them how to build them and manage their own stocks. Mampilly also shows his subscribers which stocks are doing well by giving them an inside look at his own portfolio, and thus far he’s gained hundreds of thousands of subscribers. Read this article at Seeking Alpha.